Basilic Fly Studio SME IPO: Bumper listing, stock debuts at 179% premium on NSE
Basilic Fly Studio, a visual effects (VFX) studio operator, made a bumper debut on the NSE SME platform on Tuesday, listing at Rs 271, a premium of 179% over its issue price of Rs 97.
The company’s shares opened at Rs 271 and touched an intraday high of Rs 284.55, before closing at Rs 270.50.
The IPO was oversubscribed 286.61 times, with bids for 146.06 crore equity shares as against the issue size of 50.96 lakh shares.
The company had set the price band for the issue at Rs 92-97 per share. The total issue size was Rs 66.35 crore, or 68,40,000 shares. The public issue consisted of fresh issue of 62,40,000 shares aggregating up to Rs 60.53 crore, and an offer for sale of 6,000,00 shares totalling up to Rs 5.83 crore.
The company will use the proceeds of the IPO to set up a facility in Hyderabad and Salem, and add the infrastructure to existing facilities in Chennai and Pune.
The strong listing of Basilic Fly Studio is a positive sign for the SME IPO market, which has seen a few tepid listings in recent months.
The benchmark equity indices, NSE Nifty 50 and BSE Sensex, gained over half a percent in the early morning trade today amid mostly positive global cues.
- 22 Sep
Samhi Hotels Stock Lists with 6.75% Premium, Analysts Recommend Booking Profits
Samhi Hotels stock made a weak debut on the stock exchanges, listing at a premium of just 6.75% over the IPO price. Several analysts have recommended booking profits in the stock, citing its loss-making status and negative net worth.
- 22 Sep
Signature Global IPO Subscribed 11.88 Times on Final Day
The Signature Global IPO was subscribed 11.88 times on the final day of bidding. The company will use the proceeds to repay debt and for land acquisitions and general corporate purposes. The IPO is expected to list on October 4, but this may change due to the new timeline of T+3.
- 22 Sep
Sai Silks IPO Oversubscribed 4.4 Times on Final Day of Bidding
Sai Silks IPO was oversubscribed 4.4 times on the final day of bidding, with qualified institutional buyers and high networth individuals supporting the issue on closing day. The net fresh issue proceeds will be utilized by the company mainly for the setting up of 30 new stores, two warehouses, working capital requirements and repaying debts. The trading in its equity shares will commence with effect from October 4, as per the IPO schedule.
- 22 Sep
Pharma company Valiant Laboratories to go public on September 27
Pharma company Valiant Laboratories is going public on September 27 at a price band of Rs 133-140 per share. The company plans to raise Rs 152.46 crore via the IPO. Proceeds will be used to fund the expenditure for setting up a manufacturing facility for speciality chemicals and for working capital requirements and general corporate purposes. Valiant Laboratories is a Mumbai-based API and bulk drug manufacturing company with a focus on Paracetamol. It is owned by the promoters including Dhanvallabh Ventures LLP, which holds 62.5 percent shareholding. Valiant Organics, the listed entity on the BSE and NSE, is the promoter of Dhanvallabh Ventures LLP with 73.15 percent stake.
- 21 Sep
Unihealth Consultancy makes tepid debut on NSE Emerge
Unihealth Consultancy, a healthcare service provider, made a tepid debut on the NSE Emerge platform on September 21, listing at Rs 135, a 2.2 percent premium over its issue price of Rs 132. The stock was trading at Rs 137.30 at 11.40 am. The company has a number of positives going for it, such as its strong growth potential, its diversified business model, and its focus on the African market. However, investors who are considering investing in Unihealth Consultancy should carefully consider the company's fundamentals, the current market conditions, and their own risk appetite before making a decision.